Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Neurophysiological Effects of Medication Tapering During Treatment With ECAP Controlled Closed-loop Spinal Cord Stimulation Trial Periods

NCT07413731 is registered in ClinicalTrials.gov with Brai²n as lead sponsor.

NCT NCT07413731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Neurophysiological Effects of Medication Tapering During Treatment With ECAP Controlled Closed-loop Spinal Cord Stimulation Trial Periods
Lead sponsor
Brai²n
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2025
Completion date
April 3, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurophysiological sensitivity to spinal cord stimulation, persistent spinal pain syndrome type 2 (psps-t2), lower spine, spinal cord sensitivity to neurostimulation